We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
- Authors
Dochez, Vincent; Caillon, Hélène; Vaucel, Edouard; Dimet, Jérôme; Winer, Norbert; Ducarme, Guillaume
- Abstract
Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and ROMA algorithms. Serum CA125 assay has low sensitivity in the early stages and can be increased in certain conditions such as menstruation or endometriosis. The level of HE4 is overexpressed in ovarian tumors. Its specificity is 94% and its level is not affected by endometriosis cysts. The combined measures of CA125 and HE4 have proved to be highly efficient with an area under the curve (AUC) of up to 0.96. Furthermore, this combined measure of CA125 can correct the variations in HE4 which are due to smoking or contraception combining estrogen plus progestin. While the specificity of RMI sometimes reaches 92%, the rather low AUC of 0.86 does not make it the best diagnostic tool. The specificity of ROMA is lower than HE4 (84% compared to 94%). To date, the most efficient biological diagnostic tool to diagnose ovarian cancer is the combination of CA125 and HE4.
- Subjects
OVARIAN cancer diagnosis; BIOLOGICAL tags; ENDOMETRIOSIS; MENSTRUATION; PROGESTATIONAL hormones
- Publication
Journal of Ovarian Research, 2019, Vol 12, Issue 1, pN.PAG
- ISSN
1757-2215
- Publication type
Article
- DOI
10.1186/s13048-019-0503-7